A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT06124157 · RECRUITING
Trial details
- NCT number
- NCT06124157
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2030-12-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.